EltaMD AI Visibility Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

EltaMD holds a valid recommendation coverage of 31.82% in the dermatologist-recommended skin care category for October 2026, ranking eighth among ten tracked brands. The brand appears in AI-generated answers at a 32.60% presence rate but converts that presence into valid recommendations at nearly the same rate, indicating that when EltaMD is mentioned, it is usually recommended. The clearest weakness is first-position placement: EltaMD earns the rank-one recommendation in only 2.99% of qualified observations. The clearest opportunity is converting its existing visibility into higher placement within recommendation shortlists, particularly on platforms where it already appears.

Who This Report Is For

This report is for EltaMD marketing, brand, and ecommerce leaders who need to understand how AI search and assistant platforms recommend dermatologist-recommended skin care brands, where EltaMD appears in those recommendations, and where the brand is losing shortlist positions to competitors.

Report Card

Executive Summary

EltaMD is visible in AI-generated recommendations for dermatologist-recommended skin care brands, but it is not a leading recommendation. The brand recorded 251 mentions across 770 qualified observations in October 2026, a raw mention presence rate of 32.60%. It earned 245 valid recommendations, a valid recommendation coverage of 31.82%, placing it eighth among the ten tracked brands.

The gap between presence and recommendation is narrow for EltaMD. When the brand appears in an AI response, it is almost always included in the recommendation shortlist. This is a positive signal: EltaMD does not suffer from the visibility-without-recommendation problem that affects some brands. The issue is that EltaMD simply does not appear in enough answers to compete at the top of the category.

EltaMD's strongest platform signal is on ChatGPT, where it recorded a 31.11% valid recommendation coverage and a 7.78% rank-one rate. Its weakest platform signal is on Gemini, where it earned a 36.17% coverage rate but a 0.00% rank-one rate, meaning it appears in recommendations but never as the first choice. On Perplexity, EltaMD recorded a 29.47% coverage rate and a 3.16% rank-one rate.

The brand's top-three recommendation rate is 11.17%, meaning it appears in the top three positions in roughly one of every nine qualified observations. Its rank-one rate is 2.99%, or roughly one in thirty-three. These placement rates are well below category leaders CeraVe (81.95% top-three, 54.94% rank-one) and La Roche-Posay (70.78% top-three, 18.31% rank-one).

EltaMD's net sentiment score is 0.9761, reflecting overwhelmingly positive framing among mentions. The brand recorded 245 positive mentions, 6 neutral mentions, and 0 negative mentions. This indicates that AI systems frame EltaMD favorably when they do mention it.

The clearest gap is scale of presence. EltaMD appears in 32.60% of qualified observations, compared to 96.75% for CeraVe, 94.55% for La Roche-Posay, and 73.77% for Vanicream. The brand is not being displaced from answers it already occupies; it is absent from the majority of high-intent prompts where buyers are forming their shortlists.

What EltaMD Is Winning

Questions This Section Answers

• How effectively does EltaMD convert AI mentions into valid recommendations?
• Which platform gives EltaMD its strongest first-position recommendation signal?

EltaMD's strongest win is its conversion rate from presence to recommendation. The brand recorded a 32.60% raw mention presence rate and a 31.82% valid recommendation coverage rate, a conversion ratio of 97.6%. This means that when AI systems mention EltaMD, they almost always include it in the recommendation shortlist. The brand does not suffer from the problem of being referenced without being recommended.

The brand's second win is sentiment quality. EltaMD recorded a net sentiment score of 0.9761, with 245 positive mentions, 6 neutral mentions, and 0 negative mentions. Among tracked brands, only CeraVe, La Roche-Posay, and Vanicream also recorded a negative mention count of zero. EltaMD's framing in AI responses is consistently positive.

EltaMD's third win is its ChatGPT performance. On ChatGPT, the brand recorded a 31.11% valid recommendation coverage rate and a 7.78% rank-one rate. This rank-one rate is higher than its overall rank-one rate of 2.99%, indicating that ChatGPT is more likely than other platforms to position EltaMD as a first-choice recommendation.

Where EltaMD Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How large is the presence gap between EltaMD and competitors like CeraVe, La Roche-Posay, and Vanicream?
• Why does EltaMD rarely appear in the top three or first-position recommendations?
• Which platforms show inconsistent recommendation placement for EltaMD?

EltaMD's clearest gap is presence scale. The brand appears in 32.60% of qualified observations, compared to 96.75% for CeraVe, 94.55% for La Roche-Posay, 73.77% for Vanicream, 61.95% for Cetaphil, and 53.25% for Neutrogena. EltaMD is absent from more than two-thirds of the high-intent prompts where buyers are asking AI systems for dermatologist-recommended skin care brand recommendations.

The second gap is placement within recommendations. EltaMD's top-three rate is 11.17%, compared to 81.95% for CeraVe, 70.78% for La Roche-Posay, 32.47% for Vanicream, and 30.52% for Cetaphil. Even when EltaMD is recommended, it is rarely placed in the top three positions that buyers are most likely to act on.

The third gap is first-position placement. EltaMD's rank-one rate is 2.99%, compared to 54.94% for CeraVe, 18.31% for La Roche-Posay, 7.40% for Vanicream, and 3.38% for Cetaphil. EltaMD is almost never the first brand AI systems name when answering dermatologist-recommended skin care questions.

The fourth gap is platform inconsistency. On Gemini, EltaMD recorded a 36.17% valid recommendation coverage rate but a 0.00% rank-one rate. On Perplexity, the brand recorded a 29.47% coverage rate and a 3.16% rank-one rate. On AI Overviews, EltaMD recorded a 33.51% coverage rate and a 1.55% rank-one rate. The brand appears in recommendations across platforms but rarely leads them.

Competitor displacement is a factor. CeraVe and La Roche-Posay dominate the category, with CeraVe earning 631 top-three recommendations and La Roche-Posay earning 545. EltaMD earned 86 top-three recommendations. Vanicream, which recorded the largest coverage gain since the July 2026 baseline, earned 250 top-three recommendations. The brands that are growing are also the brands that are being placed higher in shortlists.

Biggest Opportunity

Questions This Section Answers

• Which prompt cluster offers EltaMD the clearest path to expanding recommendation volume?
• What would happen to EltaMD's recommendation volume if its presence rate matched Cetaphil or Neutrogena?

EltaMD's biggest opportunity is increasing its presence in high-intent prompts where it is currently absent. The brand converts presence to recommendation at a 97.6% rate, meaning that if EltaMD appears in more answers, it will almost certainly be recommended in those answers. The path from reference to recommendation is already established; the brand needs to expand the number of prompts where it is referenced at all.

The specific opportunity is in the Brand Recommendation cluster, which captures discovery and consideration-stage questions such as "What is the best face wash for Accutane?" and "What do dermatologists recommend for facial cleanser?" These are the prompts where buyers are forming their shortlists. EltaMD appears in 32.60% of qualified observations in this cluster. Increasing that presence rate to match mid-tier competitors such as Cetaphil (61.95%) or Neutrogena (53.25%) would roughly double the brand's recommendation volume without requiring any improvement in conversion rate.

Competitive Landscape

Questions This Section Answers

• Where does EltaMD rank against CeraVe, La Roche-Posay, and Vanicream on top-three and rank-one recommendation rates?
• What does EltaMD's average recommended rank of 3.92 say about its position even when it is recommended?

CeraVe and La Roche-Posay hold dominant recommendation-stage strength in the dermatologist-recommended skin care category, with CeraVe earning a top-three recommendation in 81.95% of qualified observations and La Roche-Posay in 70.78%. EltaMD sits in the lower tier of the tracked set, ranking eighth by top-three rate and eighth by valid recommendation coverage.

Average recommended rank covers rank-eligible recommendations only.

EltaMD's position in the table reflects a brand that is recommended when it appears but does not appear often enough to compete with the category leaders. Its average recommended rank of 3.92 is higher than CeraVe (1.66), La Roche-Posay (2.46), Vanicream (3.57), and Cetaphil (3.38), meaning that even when EltaMD is recommended, it tends to be placed lower in the list than these competitors.

Prompt Evidence

ChatGPT / Brand Recommendation Prompt: "What is the best face wash for Accutane?" Result: EltaMD appeared in the recommendation shortlist with a rank-one rate of 7.78% on ChatGPT, indicating it is occasionally positioned as a first-choice option for this high-intent prompt.

Gemini / Brand Recommendation Prompt: "What do dermatologists recommend for facial cleanser?" Result: EltaMD was mentioned but not recommended in the top three positions. The brand recorded a 0.00% rank-one rate on Gemini, indicating it appears in answers but is never positioned as the first recommendation.

Perplexity / Brand Recommendation Prompt: "What is the highest rated body lotion?" Result: EltaMD appeared in the recommendation shortlist with a 29.47% coverage rate on Perplexity, but its rank-one rate was only 3.16%, indicating it is included but rarely leads the recommendation.

AI Overviews / Brand Recommendation Prompt: "What are the top 10 best skincare brands?" Result: EltaMD was mentioned in 34.02% of AI Overviews responses but earned a top-three recommendation in only 9.79% of them, indicating the brand is referenced as context rather than positioned as a leading recommendation.

What CiteWorks Studio Would Do Next

Questions This Section Answers

• What are the five phases of the AI visibility plan outlined for EltaMD?
• How does the plan propose to expand EltaMD's presence in high-intent prompt clusters?

Phase 1: AI Visibility Market Discovery Audit Map EltaMD's current presence across all six tracked platforms, identify the specific prompt categories where the brand is absent, and quantify the gap between presence and recommendation at the prompt level.

Phase 2: Recommendation Readiness Plan Prioritize the high-intent prompt clusters where EltaMD has the highest conversion rate from presence to recommendation and build a plan to expand presence in those clusters first.

Phase 3: Owned Answer Layer Buildout Develop owned content that directly addresses the questions AI systems are answering, with clear, extractable statements about EltaMD's dermatologist-recommended positioning and product efficacy.

Phase 4: Citation / Authority Layer Development Strengthen the public evidence layer by ensuring that dermatology and beauty editorial sources, retail pages, and review platforms carry consistent, positive framing about EltaMD that AI systems can retrieve and synthesize.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track EltaMD's presence rate, valid recommendation coverage, top-three rate, and rank-one rate month over month to measure whether presence expansion is converting into higher placement.

Why This Matters

AI presence alone is not enough. EltaMD already converts presence to recommendation at a 97.6% rate, meaning that when the brand appears in an AI response, it is almost always recommended. The problem is that EltaMD appears in only 32.60% of qualified observations, while category leaders appear in more than 90%. The brand is losing shortlist positions not because it is being displaced, but because it is absent from the majority of high-intent prompts where buyers are forming their consideration sets.

The next move is targeted expansion of the prompt, page, and citation layers. EltaMD needs to be referenced in more answers, not just recommended more often within the answers it already appears in. This requires building owned content that directly addresses the questions AI systems are answering, strengthening the public evidence layer that AI systems retrieve from, and ensuring that dermatology and beauty editorial sources carry consistent, positive framing about the brand.

Core Metrics

Sentiment Score

Questions This Section Answers

• How is EltaMD's net sentiment score calculated from its mention classifications?
• Why does high sentiment alone not guarantee stronger AI recommendation placement for EltaMD?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

EltaMD's sentiment score is 0.9761. This is calculated from 245 positive mentions, 6 neutral mentions, and 0 negative mentions across 251 total mentions.

This matters because unclassified mention counts are misleading. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. EltaMD's sentiment score indicates that AI systems frame the brand positively when they mention it, which is a strong signal. However, sentiment alone does not capture whether the brand is being recommended or simply referenced. EltaMD's challenge is not framing quality; it is presence scale and placement.

Classified sentiment is required before interpreting AI visibility. A brand with high mention volume but low sentiment may be appearing in cautionary or comparative contexts. A brand with low mention volume but high sentiment, like EltaMD, is being framed positively but is not appearing often enough to compete for shortlist positions.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of EltaMD's AI visibility and recommendation performance in the dermatologist-recommended skin care category for October 2026. It is not a client implementation case study.
2. The reporting window is October 2026. The baseline for comparison is July 2026.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The analysis is based on 770 qualified observations from a total of 800 prompt-surface observations collected. The qualification process removed 11 irrelevant prompts and 19 reserved prompts.
5. The competitor universe includes ten tracked brands: CeraVe, La Roche-Posay, Vanicream, Cetaphil, Neutrogena, Aveeno, EltaMD, SkinCeuticals, Eucerin, and Differin.
6. One public high-intent cluster was used: Brand Recommendation (C01), which captures discovery and consideration-stage questions seeking brand recommendations. The Pricing and Value (C02) and Multi-Brand Comparison (C03) clusters contained no qualified observations in October 2026.
7. Stage 0 extraction retained the query, AI platform, answer, brand outcome, recommendation placement, sentiment, and citations where exposed. Source presence is evidence about the information environment, not proof of causation.
8. A mention is defined as any appearance of EltaMD in an AI response, regardless of whether the brand is recommended.
9. A valid recommendation is defined as an appearance of EltaMD in a recommendation shortlist, as marked by the dataset. Negative, neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations unless the dataset explicitly marks them as such.
10. The unique question count for October 2026 was 666. The qualified observation count was 770.
11. Brand-level percentages use the 770 qualified observations as the denominator. The raw collection was 800 prompt-surface observations.
12. Limitations: The public benchmark does not measure market share, sales attribution, organic search ranking, social mention volume, or causality from metric movement. The Pricing and Value and Multi-Brand Comparison clusters were empty, so this report cannot address how price or value influences AI recommendations or which brand wins in direct head-to-head comparisons.

See How AI Is Recommending Your Brand

EltaMD's AI visibility challenge is not framing quality or recommendation conversion. It is presence scale. The brand converts presence to recommendation at a 97.6% rate, but it appears in only 32.60% of qualified observations. A company-level AI visibility audit can map the specific prompt categories where EltaMD is absent, identify which competitors are being recommended instead, and build a prioritized plan to expand the brand's presence in the high-intent prompts that shape buyer shortlists.